A settlement has been reached in a key legal proceeding regarding the marketing and safety of chemical hair relaxers.
Reuters reported Monday that four women who alleged that their use of chemical hair relaxers led to uterine and ovarian cancer diagnoses reached a confidential settlement in a trial that began in Chicago last week. (A settlement does not mean a defendant has admitted any wrongdoing or liability.) L’Oréal USA, the U.S. subsidiary of the largest beauty conglomerate in the world, is among the defendants. The four women who received the settlements, of undisclosed size, are MaryAnne Lindsey, Surenthia Jenkins, Miranda Lofton, and Sandra Simpson. Legal representation for the women told Allure that all defendants settled in the case.
“Our highest priority is the health and wellbeing of all our consumers. Our products are subject to a rigorous scientific evaluation of their safety by experts who also ensure that we strictly follow all regulations in every market in which we operate,” a spokesperson for L’Oréal USA wrote to Allure. “We stand by the safety of SoftSheen-Carson’s products,” the specific L’Oréal brand that was named in the complaints.
“From our first client meetings to the morning of opening statements, MaryAnne, Surenthia, Miranda and Sandra stood firm, and I’m proud they have reached a resolution through the settlement of their cases. These women trusted the Defendants’ assurances that these hair relaxer products were safe, and they have paid a heavy price for that trust,” said the group’s attorney, Danielle Ward Mason, in a statement to Allure. “From the very beginning, our goal has been to make sure women harmed by these products are heard and compensated, and that the companies that put them on the market are held accountable.
“Our team came to Cook County ready to put these cases in front of a jury, and I’m incredibly proud of how hard everyone fought and of the result we achieved for these clients. I hope this resolution gives these four women a sense of justice after everything they have been through,” the statement continues. “This is an important step, but our work is far from over. Every woman harmed by these products deserves justice, and the next generation deserves real protections and honest warnings about their safety. I will keep fighting until every woman harmed by these products gets the justice she deserves.”
Recent research on the health implications of chemical hair straighteners (including heightened risks of ovarian and uterine cancers), which are most often created for and marketed to Black women, has set off a tsunami of lawsuits against multiple companies that manufacture relaxers in recent years. Reuters reported there are over 12,700 cases consolidated in front of a Chicago judge. In September, Arizona’s attorney general also sued L’Oréal for consumer fraud, alleging that the conglomerate downplayed the health risks of the products. (L’Oréal told Allure at the time that it “believe[s] the allegations made in this lawsuit have neither legal nor scientific merit.”)
This is the first settlement of its nature Allure has found in its reporting. What it might mean for the rest of the cases—and the future of chemical hair straighteners—remains to be seen.
For more on beauty’s legal landscape, see:
• A Full Timeline of the Case Against Celebrity Aesthetician Sonya Dakar
• A New Lawsuit Alleges Frédéric Fekkai’s Hair Salon Was Epstein’s “Epicenter for Victim Grooming”
• RFK Jr.’s Sidestepping of the FDA on Peptides Access Sets a Scary Precedent
Disclaimer : This story is auto aggregated by a computer programme and has not been created or edited by DOWNTHENEWS. Publisher: www.allure.com










